RiHN launch event: Targeted healthcare production: Where is it needed most?

Date: March 26, 2015

Location: The Engine Shed, Bristol

Personalised medicine is set to become a €2bn industry by 2018 and Re-Distributed Manufacturing (RDM) can support this growth. Manufacturing outside a centralised factory enables faster response, lower cost or better preservation of sensitive goods. RDM can provide tailored, right-first-time treatments to all patients, allowing the best therapy for an individual patient to be rapidly determined.
The Redistributed Manufacturing in Healthcare Research Network (RiHN) aims to deliver a single vision of the research needed to position the UK at the forefront of healthcare manufacturing. Network partners include cross disciplinary researchers from the University of Cambridge Institute for Manufacturing (IfM), Brunel University and the Universities of Nottingham, Newcastle and the West of England.
Benefits of attending
You will have the opportunity to engage with key stakeholders in an expert forum and influence future R&D in healthcare manufacturing. There will be a call to participate in feasibility studies and identify future research themes within, for example, medical devices, pharmaceuticals, advanced therapeutics (cell and tissue) and dentistry and diagnostics.
The event will also feature a keynote address from Professor Sir Mark Walport, the UK Government’s Chief Scientific Advisor. Full details of the event, including the day’s schedule, can be seen on the RiHN event listings page.